AptarGroup(ATR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ATR AptarGroup

Closed 09-18 16:00:00 EDT

153.07

+0.04

+0.03%

盘后153.07

+0.000.00%

16:53 EDT

High155.49	Low152.71	Vol214.22K
Open153.76	D1 Closing153.03	Amplitude1.82%
Mkt Cap10.16B	Tradable Cap10.08B	Total Shares66.39M
T/O32.92M	T/O Rate0.33%	Tradable Shares65.86M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"ATR","market":"US","secType":"STK","nameCN":"AptarGroup","latestPrice":153.07,"timestamp":1726689600000,"preClose":153.03,"halted":0,"volume":214216,"hourTrading":{"tag":"盘后","latestPrice":153.07,"preClose":153.07,"latestTime":"16:53 EDT","volume":16638,"amount":2546778.66,"timestamp":1726692808063},"delay":0,"floatShares":65859132,"shares":66388414,"eps":4.751038,"marketStatus":"Closed","change":0.04,"latestTime":"09-18 16:00:00 EDT","open":153.76,"high":155.49,"low":152.71,"amount":32915016.7344,"amplitude":0.018166,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.751038,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1726732800000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":735537600000,"exchange":"NYSE","adjPreClose":153.03,"dividendRate":0.010714,"postHourTrading":{"tag":"盘后","latestPrice":153.07,"preClose":153.07,"latestTime":"16:53 EDT","volume":16638,"amount":2546778.66,"timestamp":1726692808063},"volumeRatio":1.115797,"impliedVol":0.1447,"impliedVolPercentile":0.2302},"requestUrl":"/m/hq/s/ATR","defaultTab":"news","newsList":[{"id":"2468310315","title":"Calculating The Intrinsic Value Of AptarGroup, Inc. (NYSE:ATR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2468310315","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468310315?lang=en_us&edition=fundamental","pubTime":"2024-09-19 00:04","pubTimestamp":1726675487,"startTime":"0","endTime":"0","summary":"The projected fair value for AptarGroup is US$187 based on 2 Stage Free Cash Flow to Equity. Current share price of US$153 suggests AptarGroup is potentially trading close to its fair value. The US$162 analyst price target for ATR is 14% less than our estimate of fair value. How far off is AptarGroup, Inc.  from its intrinsic value?Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the forecast future cash flows of the company and discounting them back to today's value. Our analysis will employ the Discounted Cash Flow  model. Don't get put off by the jargon, the math behind it is actually quite straightforward.Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model.Present Value of 10-year Cash Flow  = US$3.4b. Terminal Value = FC","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/99fpOF9hSvsoMr4zPi4pGw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/65c4c58ffc9609b16d881252f1800f75","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/99fpOF9hSvsoMr4zPi4pGw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/65c4c58ffc9609b16d881252f1800f75"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/calculating-intrinsic-value-aptargroup-inc-160447153.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4211","TV","DCF","FCF","NYSE","BK4100","BK4126","ATR"],"gpt_icon":0},{"id":"2468589008","title":"Azitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR Inhibitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2468589008","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468589008?lang=en_us&edition=fundamental","pubTime":"2024-09-18 21:00","pubTimestamp":1726664400,"startTime":"0","endTime":"0","summary":"BRANFORD, Conn., September 18, 2024----Azitra, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced the U.S. Food and Drug Administration  has granted Fast Track Designation for topically applied ATR-04 to treat moderate to severe Epidermal Growth Factor Receptor inhibitor  associated dermal toxicity.Azitra, Inc. is an early-stage clinical biopharmaceutical company focused on developing innovative therapies for precision dermatology using engineered proteins and topical live biotherapeutic products. The Company has built a proprietary platform that includes a microbial library comprised of approximately 1,500 unique bacterial strains that can be screened for unique therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the Company's library of strains for drug like molecules. The Company's initial focus is","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azitra-receives-fast-track-designation-130000891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","FAST","ATR","BK4126","AZTR"],"gpt_icon":0},{"id":"2468323908","title":"Astron Full Year 2024 Earnings: AU$0.16 loss per share (vs AU$0.06 loss in FY 2023)","url":"https://stock-news.laohu8.com/highlight/detail?id=2468323908","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468323908?lang=en_us&edition=fundamental","pubTime":"2024-09-18 04:19","pubTimestamp":1726604352,"startTime":"0","endTime":"0","summary":"Astron ( ASX:ATR ) Full Year 2024 Results Key Financial Results Revenue: AU$12.2m (down 16% from FY 2023). Net loss...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice2-main-header/1585186553865"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-atr/astron-shares/news/astron-full-year-2024-earnings-au016-loss-per-share-vs-au006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ATR"],"gpt_icon":0},{"id":"2468233998","title":"Insider Sale: Segment President Hedi Tlili Sells 1,375 Shares of AptarGroup Inc (ATR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2468233998","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468233998?lang=en_us&edition=fundamental","pubTime":"2024-09-17 01:00","pubTimestamp":1726506034,"startTime":"0","endTime":"0","summary":"Hedi Tlili, Segment President of AptarGroup Inc , sold 1,375 shares of the company on September 13, 2024. The transaction was reported in a recent SEC Filing. Following this transaction, the insider now owns 9,379 shares of AptarGroup Inc.GuruFocus has detected 6 Warning Signs with ATR.AptarGroup Inc is a global provider of a broad range of innovative dispensing, sealing, and active packaging solutions for the beauty, personal care, home care, prescription drug, consumer health care, injectables, food, and beverage markets.Over the past year, the insider has sold a total of 6,009 shares and has not made any purchases. This recent sale is part of a broader trend observed within the company, where there have been 19 insider sells and no insider buys over the past year.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/uc2260_iXwFQXP4HDmc7AQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/1b44d2c4e6c23dda815a303234449258","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/uc2260_iXwFQXP4HDmc7AQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/1b44d2c4e6c23dda815a303234449258"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-sale-segment-president-hedi-170034461.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4126","ATR"],"gpt_icon":0},{"id":"2466494553","title":"Insider Sale: Segment President Gael Touya Sells 3,300 Shares of AptarGroup Inc (ATR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2466494553","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466494553?lang=en_us&edition=fundamental","pubTime":"2024-09-11 05:00","pubTimestamp":1726002047,"startTime":"0","endTime":"0","summary":"AptarGroup Inc , a leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing, and active material science solutions, has reported an insider sale according to a recent SEC Filing. Gael Touya, the Segment President of AptarGroup Inc, sold 3,300 shares of the company on September 9, 2024. After this transaction, the insider owns 32,165 shares of the company.GuruFocus has detected 6 Warning Signs with ATR.The shares were sold at a price of $151.62, valuing the transaction at approximately $500,346. This sale follows a pattern observed over the past year, where Gael Touya has sold a total of 6,800 shares and has not purchased any shares.Looking at the broader insider transaction trend for AptarGroup Inc, there have been no insider purchases but 18 insider sales over the past year. This could be indicative of sentiment among the insiders about the stocks valuation and future prospects.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/uc2260_iXwFQXP4HDmc7AQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/1b44d2c4e6c23dda815a303234449258","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/uc2260_iXwFQXP4HDmc7AQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/1b44d2c4e6c23dda815a303234449258"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-sale-segment-president-gael-210047306.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ATR","BK4126"],"gpt_icon":0},{"id":"2466469717","title":"SON or ATR: Which Is the Better Value Stock Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2466469717","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2466469717?lang=en_us&edition=fundamental","pubTime":"2024-09-10 23:40","pubTimestamp":1725982806,"startTime":"0","endTime":"0","summary":"Investors interested in stocks from the Containers - Paper and Packaging sector have probably already heard of Sonoco  and AptarGroup . But which of these two stocks is more attractive to value investors?We'll need to take a closer look to find out.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, and our Style Scores highlight companies with specific traits.Right now, Sonoco is sporting a Zacks Rank of #2 , while AptarGroup has a Zacks Rank of #3 . This means that SON's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. But this is just one piece of the puzzle for value investors.Sonoco Products Company  : Free Stock Analysis Report. To read this article on Zacks.com click here.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d6hN0_BhikrNdWTnix6fng--~B/aD03NDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d6hN0_BhikrNdWTnix6fng--~B/aD03NDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/son-atr-better-value-stock-154006539.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4136","BK4126","SON","ATR"],"gpt_icon":0},{"id":"2464035216","title":"AptarGroup (NYSE:ATR) shareholders have earned a 6.2% CAGR over the last five years","url":"https://stock-news.laohu8.com/highlight/detail?id=2464035216","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464035216?lang=en_us&edition=fundamental","pubTime":"2024-08-31 22:15","pubTimestamp":1725113709,"startTime":"0","endTime":"0","summary":"The main point of investing for the long term is to make money. But more than that, you probably want to see it rise...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2041000-choice2-main-header/1585186810333","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2041000-choice2-main-header/1585186810333"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-atr/aptargroup/news/aptargroup-nyseatr-shareholders-have-earned-a-62-cagr-over-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4126","NYSE","ATR"],"gpt_icon":0},{"id":"2463581762","title":"Pepe Fork (PORK) Hits Multi-Month High, Market Bets on PEPE Overtake","url":"https://stock-news.laohu8.com/highlight/detail?id=2463581762","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463581762?lang=en_us&edition=fundamental","pubTime":"2024-08-31 01:00","pubTimestamp":1725037200,"startTime":"0","endTime":"0","summary":"Pepe Fork  surged to $0.00000023, logging double-digit gains before witnessing a correction.PORK's daily trading volume has surged 130% over the past 24 hours, hitting $7.02 million, the highest since June 17.Despite declining momentum, the market speculates PORK could outperform Pepe  in the short term.PORK’s daily trading volume has also spiked by over 130% during this period. Currently at $7.02 million, PORK’s trading volume has reached its highest level since June 17.“$PORK 24-hour volume is just $0.5M less than $PEPE, yet PEPE’s market cap is 64x that of PORK. You really think PORK won’t flip PEPE again? It’s not a question of if. It’s when?”Another X user also drew attention to the comparison between PORK and PEPE’s 24-hour trading volumes, urging the market to “study” PORK.Read more: 7 Hot Meme Coins and Altcoins that are Trending in 2024. At press time, the RSI has dropped to 64.89, indicating that while buying pressure remains high, selling activity has begun to take hold.","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2024/01/bic_Altcoin_Season-covers_positive-850x478.jpg.optimal.jpg","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2024/01/bic_Altcoin_Season-covers_positive-850x478.jpg.optimal.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://beincrypto.com/pork-skyrockets-to-multi-month-highs/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BK4126","RSI","BK4150","ATR"],"gpt_icon":0},{"id":"2463789767","title":"Berry Global Stock Boasts Strong Prospects Despite Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2463789767","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463789767?lang=en_us&edition=fundamental","pubTime":"2024-08-31 00:11","pubTimestamp":1725034260,"startTime":"0","endTime":"0","summary":"However, Berry Global has been witnessing weakness across most of its segments. Weakness in the food service market and reduced selling prices, owing to the pass-through of lower resin prices, are affecting the Consumer Packaging International segment. The Flexibles segment is experiencing weakness due to softness in North American transportation and shrink film markets. Reduced selling prices, owing to pass-through of lower resin prices, are also affecting the Health, Hygiene, & Specialties segment.The company has a significant presence in the international markets. As a result, its financial performance is subject to various risks like the foreign currency exchange rate, interest","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qrTEnGW9U6HDdiP7B9O9Vw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/14ab53699e12e219d706826c5d2d647f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qrTEnGW9U6HDdiP7B9O9Vw--~B/aD02MDE7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/14ab53699e12e219d706826c5d2d647f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/berry-global-stock-boasts-strong-161100808.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4126","BK4585","LU2098885051.SGD","LU1923621640.USD","BK4588","BK4104","LU0385154629.USD","LU2125910179.SGD","LU1303367103.USD","PKG","FERG","LU1165135440.EUR","LU1721427968.SGD","ATR","LU2360106947.USD","LU0471298694.HKD","LU0471298777.SGD","BERY","LU2125910336.SGD","BK4136","LU1543694498.USD"],"gpt_icon":0},{"id":"2463592276","title":"Insider Sale: Segment President Marc Prieur Sells 3,500 Shares of AptarGroup Inc (ATR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2463592276","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463592276?lang=en_us&edition=fundamental","pubTime":"2024-08-30 13:23","pubTimestamp":1724995421,"startTime":"0","endTime":"0","summary":"Marc Prieur, Segment President of AptarGroup Inc , sold 3,500 shares of the company on August 29, 2024. The transaction was reported in a recent SEC Filing. Following this transaction, the insider now owns 16,616 shares of AptarGroup Inc.GuruFocus has detected 6 Warning Signs with ATR.AptarGroup Inc is a global provider of a range of packaging, dispensing, and sealing solutions, primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectables, and food and beverage industries.Over the past year, the insider has sold a total of 9,900 shares and has not purchased any shares. This recent sale is part of a broader trend observed within the company, where there have been 17 insider sells and no insider buys over the past year.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/uc2260_iXwFQXP4HDmc7AQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/1b44d2c4e6c23dda815a303234449258","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/uc2260_iXwFQXP4HDmc7AQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/1b44d2c4e6c23dda815a303234449258"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-sale-segment-president-marc-052341887.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4126","ATR"],"gpt_icon":0},{"id":"2463280805","title":"Binance Coin (BNB) Steady as Market Consolidation Eases Volatility Fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2463280805","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463280805?lang=en_us&edition=fundamental","pubTime":"2024-08-29 17:19","pubTimestamp":1724923196,"startTime":"0","endTime":"0","summary":"BNB's price is consolidating with a flattening 20-day EMA and 50-day SMA, signaling reduced volatility.BNB's ATR and Bollinger Bandwidth have declined, confirming lower price fluctuations.A break above the range could push BNB to $560.90, while increased selling might drop it to $522.90.Binance Coin  has experienced a gradual decrease in market volatility over the past few days, as its price begins to consolidate within a defined range.This consolidation is evident on the one-day chart, where BNB’s 20-day exponential moving average  and 50-day simple moving average  have started to flatten out, indicating a period of reduced price movement.Since August 26, BNB’s 20-day EMA and 50-day SMA have both flattened. When an asset’s moving averages flatten, it signals market indecision, where neither buyers nor sellers have enough strength. This typically indicates that the market is trending sideways.Additionally, BNB’s downward-trending Bollinger Bandwidth supports this view. This indicator h","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2024/05/BNB-Chain-Artificial-Intelligence-850x478.png","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2024/05/BNB-Chain-Artificial-Intelligence-850x478.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://beincrypto.com/bnb-steady-as-market-consolidation-eases/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["ATR","BK4126"],"gpt_icon":0},{"id":"2463494328","title":"4 Containers - Paper and Packaging Stocks to Buy in a Promising Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2463494328","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463494328?lang=en_us&edition=fundamental","pubTime":"2024-08-28 23:55","pubTimestamp":1724860500,"startTime":"0","endTime":"0","summary":"The Zacks Containers - Paper and Packaging industry will continue to benefit from solid demand from consumer-oriented end-markets, as packaging is integral to product distribution. Booming e-commerce activities, and rising demand for sustainable and eco-friendly packaging options due to increasing environmental concerns will continue to drive the industry’s growth. Pricing actions implemented by industry players will help offset the impacts of the ongoing supply-chain disruptions and rising costs.Companies like Packaging Corporation of America PKG, Brambles Limited BXBLY, AptarGroup ATR and Greif, Inc. GEF are set to gain from the demand trends.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_yW8jcoyCjylDpJ5CxzSzQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0fde9970c2cb883b27254f8e2ba65e74","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_yW8jcoyCjylDpJ5CxzSzQ--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0fde9970c2cb883b27254f8e2ba65e74"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/4-containers-paper-packaging-stocks-155500440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BXB.AU","BK7095","BXBLY","BK4137","LU0385154629.USD","PKG","BK4588","LU0471298777.SGD","LU2360106947.USD","BK4136","BK4159","BK4585","ATR","ATR.AU","CAGR","GEF","BK7064","LU0471298694.HKD","BK4126"],"gpt_icon":0},{"id":"2462846850","title":"Azitra Doses First Patient in ATR-12 Study for Rare Skin Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2462846850","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2462846850?lang=en_us&edition=fundamental","pubTime":"2024-08-28 21:07","pubTimestamp":1724850433,"startTime":"0","endTime":"0","summary":"Azitra  said Wednesday that it has dosed the first patient in a phase 1b clinical study of its lead drug candidate, ATR-12, for the potential treatment of Netherton syndrome, a rare genetic skin disorder.The company said the trial will include about 12 adult patients, who will receive twice-daily treatments over 14 days. The study's primary focus is on safety and tolerability, with efficacy and biomarker assessments as secondary and exploratory goals, the company said.Azitra said it plans to release interim safety data early next year and full results in the second half.Price: 0.6870, Change: -0.02, Percent Change: -2.55","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ATR","AZTR","BK4126"],"gpt_icon":0},{"id":"2462345054","title":"Azitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2462345054","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2462345054?lang=en_us&edition=fundamental","pubTime":"2024-08-28 20:30","pubTimestamp":1724848200,"startTime":"0","endTime":"0","summary":"BRANFORD, Conn., August 28, 2024----Azitra, Inc. , a precision dermatology company, announced that it has initiated dosing the first patient in its Phase 1b clinical trial evaluating ATR-12 for the treatment of Netherton syndrome. The study is designed to enroll approximately 12 adult patients with twice-daily treatment for 14 days, with primary endpoints focusing on safety and tolerability, and secondary and exploratory endpoints assessing efficacy signals and biomarkers. Azitra expects to report interim safety data from the Phase 1b trial in early 2025 with full results anticipated in the second half of 2025.ATR-12 is Azitra's lead candidate, a proprietary strain of Staphylococcus epidermidis engineered to express therapeutic levels of an active subunit of the LEKTI protein to treat Netherton syndrome, a chronic genetic skin disease that can be life threatening.\"Dosing the first patient in our Phase 1b trial of ATR-12 marks a vital milestone for Azitra and for patients suffering from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azitra-announces-first-patient-dosed-123000947.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ATR","BK4126","AZTR"],"gpt_icon":0},{"id":"2462144463","title":"Insider Sale: Chief Human Resources Officer Shiela Vinczeller Sells Shares of AptarGroup Inc (ATR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2462144463","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2462144463?lang=en_us&edition=fundamental","pubTime":"2024-08-28 05:00","pubTimestamp":1724792449,"startTime":"0","endTime":"0","summary":"Chief Human Resources Officer Shiela Vinczeller of AptarGroup Inc  sold 1,660 shares of the company on August 26, 2024, according to a recent SEC Filing. Following this transaction, the insider now owns 22,651 shares of the company.GuruFocus has detected 6 Warning Signs with ATR.AptarGroup Inc, a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing, and active material science solutions, has seen a notable insider selling trend. Over the past year, there have been 17 insider sells and no insider buys. The insider transaction history reflects a cautious stance from insiders, possibly suggesting their assessment of the stocks current valuation.On the day of the sale, shares of AptarGroup Inc were priced at $151.15. The company holds a market cap of approximately $10.02 billion. The price-earnings ratio of the company stands at 31.72, which is above both the industry median of 27.1 and the company's historical median.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/uc2260_iXwFQXP4HDmc7AQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/1b44d2c4e6c23dda815a303234449258","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/uc2260_iXwFQXP4HDmc7AQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/1b44d2c4e6c23dda815a303234449258"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/insider-sale-chief-human-resources-210049344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4126","ATR"],"gpt_icon":0},{"id":"2462112973","title":"AptarGroup Hits 52-Week High: What's Driving the Stock's Performance?","url":"https://stock-news.laohu8.com/highlight/detail?id=2462112973","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2462112973?lang=en_us&edition=fundamental","pubTime":"2024-08-28 00:57","pubTimestamp":1724777820,"startTime":"0","endTime":"0","summary":"Shares of AptarGroup, Inc. ATR scaled a new 52-week high of $152.67 on Tuesday before ending the session at $150.16. The increase was fueled by ATR’s strong second-quarter results.AptarGroup currently has a market capitalization of $10 billion and a Zacks Rank #2 .What’s Aiding ATR’s Price Performance?ATR shares have gained 17.5% in the past year compared with the industry’s growth of 20.9%.Some other top-ranked stocks from the Industrial Products sector are Crane Company CR, Flowserve Corporation FLS and Cintas Corporation CTAS. These three companies have a Zac","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xPh8Pq893e8oyuKffyOsGA--~B/aD00MTg7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/32d8e94aebaf848ba2ae713940d56cb7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xPh8Pq893e8oyuKffyOsGA--~B/aD00MTg7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/32d8e94aebaf848ba2ae713940d56cb7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aptargroup-hits-52-week-high-165700998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4588","BK4126","CR","BK4161","ATR","BK4137","CTAS","FLS"],"gpt_icon":0},{"id":"2461592317","title":"AZTR: First ATR-12 Patient Screened","url":"https://stock-news.laohu8.com/highlight/detail?id=2461592317","media":"Zacks Small Cap Research","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461592317?lang=en_us&edition=fundamental","pubTime":"2024-08-23 17:40","pubTimestamp":1724406000,"startTime":"0","endTime":"0","summary":"Azitra, Inc.  reported second quarter results following a $10 million raise which enabled the company to begin enrolling its ATR-12 Phase Ib trial for Netherton Syndrome. Just days after the 2Q:24 report, the company announced that the first patient for the ATR-12 trial had been screened and scheduled to initiate treatment before the end of August. A few days later, the company announced that its ATR-04 investigational new drug  application for EGFRi-related skin rash was cleared by the FDA. A Phase I/II study is planned for year-end 2024.Year to date, Azitra has been granted several patents for its ATR-12 and ATR-04 candidates, presented at numerous conferences and strengthened its balance sheet in order to advance its engineered bacterial candidates in dermatology. We recently initiated on Azitra providing a review of Netherton Syndrome, the competitive environment and factors impacting and contributing to our valuation of the enterprise. Below we provide a summary of second quarter ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_RE5M0lxOb34DVcpCF.w0w--~B/aD0xMjE2O3c9OTk2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/28999998d4d5e5cb770f80db082424f1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_RE5M0lxOb34DVcpCF.w0w--~B/aD0xMjE2O3c9OTk2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/scr.zacks.com/28999998d4d5e5cb770f80db082424f1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/aztr-first-atr-12-patient-094000033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","AZTR","ATR","BK4126"],"gpt_icon":0},{"id":"2461819538","title":"Crypto Whales Dump Notcoin (NOT) Amid Fading Hype","url":"https://stock-news.laohu8.com/highlight/detail?id=2461819538","media":"BE[IN]CRYPTO","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461819538?lang=en_us&edition=fundamental","pubTime":"2024-08-21 16:00","pubTimestamp":1724227200,"startTime":"0","endTime":"0","summary":"NOT whales have reduced holdings as price plummets, with large transactions down and netflow dropping.Netflow for large Notcoin holders has dropped 98% in 30 days, hinting at potential selling pressure.NOT’s flat RSI and declining ATR suggest market indecision; a potential price breakout or further decline looms.Notcoin , the Telegram-based tap-to-earn project, has seen a decline in whale activity as the altcoin’s price plummets.Over the past month, NOT large holders have distributed more than they have accumulated due to the altcoin’s double-digit price drop during that period.On-chain data indicates a sharp decline in the daily volume of large NOT transactions. According to IntoTheBlock, the volume of NOT transactions valued between $100,000 and $1 million has dropped by 74% over the past month.Read more: How To Buy Notcoin  and Everything You Need To Know. Furthermore, NOT’s Average True Range , which gauges market volatility, has been trending downward since August 8, reinforcing t","market":"us","thumbnail":"https://beincrypto.com/wp-content/uploads/2024/05/bic_notcoin_NOT-covers_bearish-850x478.jpg.optimal.jpg","type":0,"news_type":0,"thumbnails":["https://beincrypto.com/wp-content/uploads/2024/05/bic_notcoin_NOT-covers_bearish-850x478.jpg.optimal.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://beincrypto.com/large-holders-dump-notcoin/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"beincrypto_highlight","symbols":["BK4539","BK4150","ATR","BK4112","BK4023","BK4516","BK4595","BK4547","BK4588","RSI","LU1861558580.USD","LU1861559042.SGD","BK4535","BK4554","BK4551","BK4126","BK4585"],"gpt_icon":1},{"id":"2461837110","title":"Azitra Screens First Patient in Phase 1b Trial for Netherton Syndrome; Shares Soar After-Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2461837110","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461837110?lang=en_us&edition=fundamental","pubTime":"2024-08-21 05:31","pubTimestamp":1724189502,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["ATR","BK4139","BK4126","AZTR"],"gpt_icon":0},{"id":"2461662831","title":"Azitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2461662831","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461662831?lang=en_us&edition=fundamental","pubTime":"2024-08-21 04:15","pubTimestamp":1724184900,"startTime":"0","endTime":"0","summary":"BRANFORD, Conn., August 20, 2024----Azitra, Inc. , a precision dermatology company announced that it has successfully screened the first patient in its Phase 1b clinical trial evaluating ATR-12 for the treatment of Netherton syndrome. The patient is scheduled to initiate treatment by the end of the month. The study is designed to enroll approximately 12 adult patients with twice-daily treatment for 14 days, with primary endpoints focusing on safety and tolerability, and secondary and exploratory endpoints assessing efficacy signals and biomarkers. Azitra expects to report interim safety data from the Phase 1b trial in early 2025 with full results anticipated in the second half of 2025.ATR-12 is Azitra's lead candidate, a proprietary strain of Staphylococcus epidermidis engineered to express therapeutic levels of an active subunit of the LEKTI protein to treat Netherton syndrome, a chronic genetic skin disease that can be life threatening.ATR-12 produced higher amounts of LEKTI subunit ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/azitra-announces-first-patient-screened-201500065.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["AZTR","BK4126","BK4139","ATR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aptar.com","stockEarnings":[{"period":"1week","weight":0.01},{"period":"1month","weight":0.043},{"period":"3month","weight":0.0432},{"period":"6month","weight":0.0842},{"period":"1year","weight":0.218},{"period":"ytd","weight":0.2379}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0158},{"period":"3month","weight":0.0266},{"period":"6month","weight":0.0783},{"period":"1year","weight":0.2692},{"period":"ytd","weight":0.1846}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.","yearOnYearQuotes":[{"month":1,"riseRate":0.419355,"avgChangeRate":-0.01964},{"month":2,"riseRate":0.774194,"avgChangeRate":0.030094},{"month":3,"riseRate":0.741935,"avgChangeRate":0.026776},{"month":4,"riseRate":0.7,"avgChangeRate":0.025642},{"month":5,"riseRate":0.65625,"avgChangeRate":0.013008},{"month":6,"riseRate":0.53125,"avgChangeRate":-0.01018},{"month":7,"riseRate":0.5625,"avgChangeRate":0.012807},{"month":8,"riseRate":0.5625,"avgChangeRate":0.012472},{"month":9,"riseRate":0.40625,"avgChangeRate":-0.016584},{"month":10,"riseRate":0.612903,"avgChangeRate":0.00935},{"month":11,"riseRate":0.806452,"avgChangeRate":0.038275},{"month":12,"riseRate":0.645161,"avgChangeRate":0.017301}],"exchange":"NYSE","name":"AptarGroup","nameEN":"AptarGroup"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"AptarGroup(ATR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest AptarGroup(ATR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"AptarGroup,ATR,AptarGroup股票,AptarGroup股票老虎,AptarGroup股票老虎国际,AptarGroup行情,AptarGroup股票行情,AptarGroup股价,AptarGroup股市,AptarGroup股票价格,AptarGroup股票交易,AptarGroup股票购买,AptarGroup股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"AptarGroup(ATR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest AptarGroup(ATR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction